Among these proteins, Fis1 is thought to contribute to myocardial infarction (Cheng et al., 2020), as Mdivi-1 treatment significantly reduced the infarcted area by preventing Fis1 from binding to Drp1 (Jannuzzi et al., 2020; Li et al., 2020). This evidence concerns the gene FIS1 and myocardial infarction.